Periodontal Diseases Clinical Trial
Official title:
Development of Toothpaste for the Removal of Dental Calculus: a Double-blind, Randomized Controlled Trial.
Periodontal disease is amongst the most prevalent oral diseases worldwide and in North
America. According to the 2007/09 Canadian Health Measures Survey, 16% of Canadian adults and
24% of older adults, 60 to 79 years of age, were found to have moderate periodontal disease.
Moreover, 11% of Canadian adults were found to have calculus scores in the highest range. On
the other hand, recent reports on the prevalence of periodontitis in the US showed that 47.2%
of adults aged 30 years and older have some form of periodontal disease and 70.1% of adults
65 years and older have periodontal disease. The estimates also showed that the expenditure
for periodontal treatments in the US is about approximately $ 14.3 billion.
Since dental calculus plays an important etiological role in initiation and progression of
periodontal diseases. Investigation and investment on preventive technologies to prevent the
periodontal disease are important for any health care system and its end-users. Furthermore,
the removal and prevention of dental calculus using an effective toothpaste could reduce the
need for professional periodontal interventions or the time of these treatments that in turn
reduces their cost and other burdens on patients.
The aim of this study is to assess the efficacy of D-Tart toothpaste in removing dental
calculus compared to Crest® (Complete Whitening plus Scope, tartar control, Procter & Gamble,
Cincinnati, OH), anti-tartar toothpaste with similar pH and texture to D- Tart toothpaste.
Status | Completed |
Enrollment | 87 |
Est. completion date | April 30, 2020 |
Est. primary completion date | March 10, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Aged 18 years and over, to ensure compliance with the study instructions - Systemically healthy to exclude the possibility of calculus formation due to disease; - Has at least 20 sound natural teeth including all lower anterior teeth, the main location of calculus build up; - Having the history of previous calculus formation (at least 1.5 mm of calculus width) on the lingual surfaces of the mandibular anterior teeth after 3- 6 months of receiving a professional prophylaxis treatment, for better assessment of the toothpaste effectiveness; - Agree to follow the study instruction: adherence to study arm, for the study timeline. Exclusion Criteria: - Pregnancy: pregnant women at high risk of developing gum inflammation that usually occurs during pregnancy, which could introduce bias to the study; - any physical handicap, psychological or health conditions that might jeopardize the ability of the patient to brush his/ her teeth, these complications cause bias in the study; - Antibiotics or anti-inflammatory drugs are taken within 1 month prior to the study, to avoid bias when assessing the gum health; - Currently using Chlorhexidine oral products, since these products can affect biofilm and calculus formation, therefore they can introduce bias in our assessment of calculus removal by our toothpaste; - Sensitivity to tartar-control toothpaste; - Patients currently receiving dental treatment that would result in the removal of plaque or calculus and compromise our ability to measure calculus removed by the toothpaste; - unable to return for evaluations/study recalls, to avoid the significant loss in the number of participants; 9) Having the diagnosis of Periodontal Screening and Recording scale (PSR) of 4, these type of patients have advanced periodontitis with a high risk of tooth loss (periodontal pockets of 6 mm and more) and could bias the treatment outcomes. |
Country | Name | City | State |
---|---|---|---|
Canada | McGill University Faculty of Dentistry | Montreal | Quebec |
Lead Sponsor | Collaborator |
---|---|
Faleh Tamimi | Cégep Garneau, MEDTEQ, Mitacs, Visionaturolab INC. |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in calculus index | Calculus level in mm on teeth before and after brushing with toothpaste. | Baseline, 3 months, 9 months | |
Secondary | Modified Gingival Index | semi-quantitative assessment of gingival health around each tooth Absence of inflammation; Mild inflammation or with slight changes in color and texture but not in all portions of gingival marginal or papillary Mild inflammation, such as the preceding criteria, in all portions of gingival marginal or papillary Moderate, bright surface inflammation, erythema, edema and/or hypertrophy of gingival marginal or papillary Severe inflammation: erythema, edema and/or marginal gingival hypertrophy of the unit or spontaneous bleeding, papillary, congestion or ulceration |
Baseline, 3 months, 9 months | |
Secondary | Shaw and Murray Stain Index | Quantitative assessment of extrinsic stains on the labial and palatal/lingual surfaces of the upper and lower central and lateral incisors; The outline of the labial and lingual surfaces of all eight incisor teeth are enlarged to scale (magnification X 4) and each tooth face divided into 4-mm squares. All areas of extrinsic stain are drawn by the examiner on a grid system and then measured. | baseline, 3 months, 9 months | |
Secondary | Quigley-Hain plaque index (QHI) | semi-quantitative assessment of plaque around each tooth; Score 0: No plaque Score 1: Isolated flecks of plaque at the gingival margin Score 2: A continuous band of plaque up to 1mm at the gingival margin Score 3: Plaque greater than 1mm in width and covering up to one third of the tooth surface Score 4: Plaque covering from one thirds to two thirds of the tooth surface Score 5: Plaque covering more than two thirds of the tooth surface |
baseline, 3 months, 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04712630 -
Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft
|
N/A | |
Recruiting |
NCT03997552 -
NIPSA Versus Marginal Approach by Palatal Incision and MIST in Periodontal Regeneration
|
N/A | |
Completed |
NCT04478864 -
Knowledge, Practice and State of Periodontal Health
|
||
Completed |
NCT03507868 -
YKL-40 and IL-6 Levels in Periodontal Disease
|
||
Completed |
NCT05720481 -
Impact of Periodontal Treatment on Growth Differentiation Factor-15 Levels
|
N/A | |
Recruiting |
NCT06052150 -
Oral Health In Cirrhosis of the Liver (ORACLE)
|
||
Recruiting |
NCT06025955 -
Evaluation of Outcomes of Minimally Invasive Non- Surgical Versus Surgical Therapy in Furcation Involvement.
|
N/A | |
Recruiting |
NCT03510702 -
SCREENING OF EPIGENETIC BIOMARKERS (miRNAs) IN THE GINGIVAL SULCUS
|
||
Completed |
NCT05631600 -
Manuka Honey as an Adjunct to Non-surgical Periodontal Therapy: Clinical Study
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT05068778 -
Development of an AI App to Improve Compliance in Periodontal Maintenance Patients
|
||
Not yet recruiting |
NCT05178563 -
Mechanisms of Acute Inflammation Following Periodontal Treatment
|
N/A | |
Recruiting |
NCT06224699 -
Toothpaste With Sodium Carbonate in Patients With Gingivitis
|
N/A | |
Recruiting |
NCT06086821 -
Clinical Relevance of Different Time of Periodontal Re-evaluation
|
N/A | |
Not yet recruiting |
NCT05721313 -
Vital Root Amputation in Molars With Advanced Periodontal Furcation Involvement: a Preliminary Study
|
N/A | |
Completed |
NCT06306937 -
Serum Levels of Vitamin D and IL8 in Patients With Periodontitis
|
||
Completed |
NCT06040944 -
Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic Patients
|
||
Recruiting |
NCT04669717 -
Antibiotics as Adjuncts to Periodontal Therapy:Pharmacokinetic Considerations and Dosing Strategies
|
Phase 4 | |
Completed |
NCT05576142 -
Oral Findings in Pediatric Patients With Allergic Rhinitis and/or Asthma
|
||
Completed |
NCT03694496 -
The Effectiveness of an Oral Health Education Programme of Adolescents in Hong Kong
|
N/A | |
Completed |
NCT04017078 -
Assessment of Carotid Artery Calcifications
|